Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The analysis was based on 4,823 individuals (mean age 48 years
The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer
The compound is still working through Eli Lilly's TRIUMPH Phase 3 program, with seven additional trial readouts expected through 2026 alongside the already-reported TRIUMPH-4 data from December 2025
PMID: 41440811 3 Newborn screening and genetic diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency in Quanzhou,China
Life Clinical Research accepts no responsibility for actions taken based on this content.
General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 21.61
US$ 26.44
US$ 25.33
US$ 27.30
US$ 26.97
US$ 23.23
